Business Scope

HOME > ABOUT US > Business Scope

ISU ABXIS is the biopharmaceutical company specializing the development and marketing of rare disease therapeutics in using the recombinant protein technology.


ISU ABXIS is a top-leading company in Korea in the area of biopharmaceutical development with recombinant protein technology, and focus on the orphan therapeutics which of market size is US$17.6 Billions and consists of around 13% of the whole pharmaceutical market (Ref.).